Quantcast

Latest Caris Life Sciences Stories

2014-03-28 08:26:18

IRVING, Texas, March 28, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, continues to enhance its industry-leading comprehensive tumor profiling service, Caris Molecular Intelligence(TM), now capable of providing an industry-leading 51 drug target associations, including exciting new immunologically-based drug targets. Through these enhancements, Caris Molecular Intelligence will now provide...

2014-02-21 08:25:07

IRVING, Texas, Feb. 21, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced that former President George W. Bush, the 43(rd )President of the United States, was the featured keynote speaker at its annual sales meeting held in Phoenix, Ariz., this week. President Bush's remarks were featured as part of a conversation between the President and David D. Halbert, Chairman and CEO of Caris Life...

2014-01-30 12:28:48

International studies demonstrate importance of comprehensive tumor profiling for poor-prognosis cancer patients IRVING, Texas, Jan. 30, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present two tumor profiling studies at the 2014 Genitourinary Cancers Symposium held this week in San Francisco, Calif. Through use of the company's comprehensive tumor profiling service, Caris Molecular Intelligence,...

2014-01-18 08:20:15

Research findings enable disease molecular sub-typing to lead to more informed clinical decision-making IRVING, Texas, Jan. 18, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present a large international tumor profiling study of colorectal cancer (CRC) at the 2014 Gastrointestinal Cancers Symposium this week in San Francisco, Calif. With more than 7,000 patients comprehensively profiled by...

2014-01-17 08:22:52

Molecularly-Guided Therapies of Critical Importance for Rare Cancers with Fewer Treatment Options IRVING, Texas, Jan. 17, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present tumor profiling studies on neuroendocrine and appendiceal cancers at the 2014 Gastrointestinal Cancers Symposium held this week in San Francisco, Calif. These studies provide key clinical insights on potential treatment...

2014-01-16 16:24:37

Research uncovers clinically actionable biomarker targets and key treatment insights for colorectal, gastric, neuroendocrine and appendiceal cancer patients IRVING, Texas, Jan. 16, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present multiple tumor profiling studies at the 2014 Gastrointestinal Cancers Symposium held this week in San Francisco, Calif. This research demonstrates the impact of Caris...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related